$HAE
HAEMONETICS CORP Stock $hae

$hae Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000031314313000155 Filed on August 02, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$219.5M	$176.5M
YoY Change	24.4%	3.79%
Cost Of Revenue	$108.1M	$86.36M
YoY Change	25.21%	4.68%
Gross Profit	$111.4M	$90.11M
YoY Change	23.64%	2.99%
Gross Profit Margin	50.75%	51.06%
Selling, General & Admin	$106.8M	$67.63M
YoY Change	57.95%	40.59%
% of Gross Profit	95.87%	75.04%
Research & Development	$11.21M	$9.409M
YoY Change	19.13%	6.92%
% of Gross Profit	10.06%	10.44%
Depreciation & Amortization	$18.40M	$11.20M
YoY Change	64.29%	0.9%
% of Gross Profit	16.52%	12.43%
Operating Expenses	$118.0M	$77.03M
YoY Change	53.21%	35.38%
Operating Profit	-$6.608M	$13.08M
YoY Change	-150.52%	-54.74%
Interest Expense	-$2.600M	$300.0K
YoY Change	-966.67%	-200.0%
% of Operating Profit		2.29%
Other Income/Expense, Net	-$2.641M	$336.0K
YoY Change	-886.01%
Pretax Income	-$9.249M	$13.42M
YoY Change	-168.95%	-53.09%
Income Tax	-$1.375M	$3.628M
% Of Pretax Income		27.04%
Net Earnings	-$7.874M	$9.787M
YoY Change	-180.45%	-53.37%
Net Earnings / Revenue	-3.59%	5.55%
Basic Earnings Per Share	-$0.15	$0.19
Diluted Earnings Per Share	-$0.15	$0.19
COMMON SHARES
Basic Shares Outstanding	51.23M shares	50.97M shares
Diluted Shares Outstanding	51.23M shares	51.86M shares

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$166.3M	$236.0M
YoY Change	-29.53%	19.98%
Cash & Equivalents	$166.3M	$236.0M
Short-Term Investments
Other Short-Term Assets	$72.40M	$51.20M
YoY Change	41.41%	26.11%
Inventory	$196.7M	$126.8M
Prepaid Expenses
Receivables	$156.0M	$126.1M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$591.4M	$540.2M
YoY Change	9.48%	20.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$255.0M	$166.2M
YoY Change	53.38%	6.89%
Goodwill	$341.5M	$115.0M
YoY Change	196.84%	-0.28%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.92M	$11.08M
YoY Change	-1.4%	5.94%
Total Long-Term Assets	$888.3M	$387.9M
YoY Change	128.97%	0.91%
TOTAL ASSETS
Total Short-Term Assets	$591.4M	$540.2M
Total Long-Term Assets	$888.3M	$387.9M
Total Assets	$1.480B	$928.1M
YoY Change	59.42%	11.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$47.92M	$33.98M
YoY Change	41.02%	19.97%
Accrued Expenses	$41.50M	$25.20M
YoY Change	64.68%	-6.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$32.43M	$2.417M
YoY Change	1241.91%	164.73%
Total Short-Term Liabilities	$187.8M	$121.9M
YoY Change	54.05%	12.18%
LONG-TERM LIABILITIES
Long-Term Debt	$448.1M	$2.642M
YoY Change	16861.36%	-33.38%
Other Long-Term Liabilities	$39.38M	$21.75M
YoY Change	81.03%	37.48%
Total Long-Term Liabilities	$487.5M	$24.39M
YoY Change	1898.43%	23.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$187.8M	$121.9M
Total Long-Term Liabilities	$487.5M	$24.39M
Total Liabilities	$675.3M	$146.3M
YoY Change	361.58%	13.89%
SHAREHOLDERS EQUITY
Retained Earnings	$390.3M	$410.6M
YoY Change	-4.93%	9.89%
Common Stock	$378.9M	$341.7M
YoY Change	10.89%	12.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$774.4M	$757.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.480B	$928.1M
YoY Change	59.42%	11.38%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$7.874M	$9.787M
YoY Change	-180.45%	-53.37%
Depreciation, Depletion And Amortization	$18.40M	$11.20M
YoY Change	64.29%	0.9%
Cash From Operating Activities	$13.40M	$553.0K
YoY Change	2323.51%	-98.28%
INVESTING ACTIVITIES
Capital Expenditures	$13.09M	$8.441M
YoY Change	55.1%	-172.15%
Acquisitions	$23.12M
YoY Change
Other Investing Activities	-$22.60M	-$700.0K
YoY Change	3128.57%	-163.64%
Cash From Investing Activities	-$35.65M	-$9.189M
YoY Change	287.93%	-13.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net	$233.0K	$217.0K
YoY Change	7.37%
Cash From Financing Activities	$9.504M	$16.23M
YoY Change	-41.43%	295.78%
NET CHANGE
Cash From Operating Activities	$13.40M	$553.0K
Cash From Investing Activities	-$35.65M	-$9.189M
Cash From Financing Activities	$9.504M	$16.23M
Net Change In Cash	-$12.74M	$7.591M
YoY Change	-267.84%	-70.46%
FREE CASH FLOW
Cash From Operating Activities	$13.40M	$553.0K
Capital Expenditures	$13.09M	$8.441M
Free Cash Flow	$310.0K	-$7.888M
YoY Change	-103.93%	-117.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5174000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	49893000	USD
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	47915000	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	170111000	USD
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	155958000	USD
CY2013Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5322000	USD
CY2013Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4053000	USD
CY2013Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	375767000	USD
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	386500000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5433000	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	365040000	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	378366000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3000000	USD
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1803000	USD
CY2013Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1727000	USD
CY2012Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2013Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	427000	USD
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
CY2012Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2013Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	327000	USD
CY2013Q2	us-gaap	Assets Assets	1479630000	USD
CY2013Q1	us-gaap	Assets Assets	1461917000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	591372000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	597010000	USD
CY2013Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	129178000	USD
CY2013Q2	us-gaap	Average Remaining Maturity Of Foreign Currency Derivatives1 AverageRemainingMaturityOfForeignCurrencyDerivatives1	P1Y
CY2013Q2	us-gaap	Business Acquisition Contingent Consideration At Fair Value BusinessAcquisitionContingentConsiderationAtFairValue	6600000	USD
CY2013Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	20000000	USD
CY2013Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	21300000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	166328000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	179120000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	236047000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	228861000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7186000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-12792000	USD
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51031563	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51396952	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51396952	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51031563	shares
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	514000	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	510000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5918000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8134000	USD
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	86362000	USD
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	108131000	USD
CY2013Q2	us-gaap	Debt Instrument Description Of Variable Rate Basis DebtInstrumentDescriptionOfVariableRateBasis	LIBOR
CY2013Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	14341000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	13782000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1751000	USD
CY2013Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1751000	USD
CY2013Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	29961000	USD
CY2013Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	29552000	USD
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18357000	USD
CY2012Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11180000	USD
CY2013Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	8061000	USD
CY2013Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	7030000	USD
CY2013Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1625000	USD
CY2013Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1322000	USD
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2012Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-405000	USD
CY2013Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-51000	USD
CY2012Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.270
CY2013Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.149
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	41523000	USD
CY2013Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	45697000	USD
CY2013Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1000000	USD
CY2013Q2	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	2666000	USD
CY2012Q2	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	2105000	USD
CY2012Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1111000	USD
CY2013Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	960000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	72393000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	79306000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	279098000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	264388000	USD
CY2013Q1	us-gaap	Foreign Currency Cash Flow Hedge Derivative At Fair Value Net ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet	133300000	USD
CY2013Q2	us-gaap	Foreign Currency Cash Flow Hedge Derivative At Fair Value Net ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet	120100000	USD
CY2013Q2	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	5749000	USD
CY2013Q2	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	1327000	USD
CY2013Q2	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet	67600000	USD
CY2013Q1	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet	65600000	USD
CY2013Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-154000	USD
CY2012Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-110000	USD
CY2013Q1	us-gaap	Goodwill Goodwill	330474000	USD
CY2013Q2	us-gaap	Goodwill Goodwill	341509000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	111412000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	90113000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9249000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	13415000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3628000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1375000	USD
CY2012Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3194000	USD
CY2013Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	906000	USD
CY2013Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7377000	USD
CY2012Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9605000	USD
CY2013Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14100000	USD
CY2012Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8020000	USD
CY2013Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12845000	USD
CY2012Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	17040000	USD
CY2013Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6110000	USD
CY2012Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	5479000	USD
CY2013Q2	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	4727000	USD
CY2012Q2	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	455000	USD
CY2012Q2	us-gaap	Interest Paid Net InterestPaidNet	84000	USD
CY2013Q2	us-gaap	Interest Paid Net InterestPaidNet	2401000	USD
CY2013Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	105239000	USD
CY2013Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	116286000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	183784000	USD
CY2013Q2	us-gaap	Inventory Net InventoryNet	196673000	USD
CY2013Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	70716000	USD
CY2013Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	74259000	USD
CY2013Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7829000	USD
CY2013Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6128000	USD
CY2013Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	121117000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1479630000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1461917000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	187795000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	180144000	USD
CY2013Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	7927000	USD
CY2013Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	23150000	USD
CY2013Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	32434000	USD
CY2013Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	448119000	USD
CY2013Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	456944000	USD
CY2012Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16227000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9504000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35647000	USD
CY2012Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9189000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13402000	USD
CY2012Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	553000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-7874000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	9787000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	118020000	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	77034000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	13079000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6608000	USD
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10924000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11341000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-259000	USD
CY2013Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	60601000	USD
CY2013Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	57351000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26095000	USD
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	39377000	USD
CY2012Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	336000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2641000	USD
CY2012Q2	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	1000000	USD
CY2013Q2	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	23124000	USD
CY2012Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8441000	USD
CY2013Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13092000	USD
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	58072000	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	50213000	USD
CY2013Q2	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	262000	USD
CY2012Q2	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-18000	USD
CY2013Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	569000	USD
CY2012Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	252000	USD
CY2013Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5849000	USD
CY2012Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13246000	USD
CY2012Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	642000	USD
CY2012Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	796000	USD
CY2013Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	686000	USD
CY2013Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	673000	USD
CY2013Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	372000	USD
CY2012Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	437000	USD
CY2012Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	283000	USD
CY2013Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	385000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	641476000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	632720000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	256953000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	254976000	USD
CY2013Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	233000	USD
CY2012Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	217000	USD
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9409000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11209000	USD
CY2013Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	1300000	USD
CY2012Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	1900000	USD
CY2013Q2	us-gaap	Restructuring And Related Cost Expected Cost RestructuringAndRelatedCostExpectedCost	60000000	USD
CY2013Q2	us-gaap	Restructuring Charges RestructuringCharges	23469000	USD
CY2013Q2	us-gaap	Restructuring Reserve RestructuringReserve	22945000	USD
CY2013Q1	us-gaap	Restructuring Reserve RestructuringReserve	3262000	USD
CY2013Q2	us-gaap	Restructuring Reserve Accrual Adjustment RestructuringReserveAccrualAdjustment	327000	USD
CY2013Q2	us-gaap	Restructuring Reserve Settled With Cash RestructuringReserveSettledWithCash	3459000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	398199000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	390324000	USD
CY2012Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	176475000	USD
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	219543000	USD
CY2012Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	67625000	USD
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	106811000	USD
CY2012Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2417000	USD
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3013000	USD
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2791
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2622
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0141
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0092
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.68
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.78
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2012Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
CY2013Q2	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	81465	shares
CY2012Q2	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	84514.000	shares
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	769182000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	774378000	USD
CY2012Q2	us-gaap	Tax Benefit From Stock Options Exercised1 TaxBenefitFromStockOptionsExercised1	1050000	USD
CY2013Q2	us-gaap	Tax Benefit From Stock Options Exercised1 TaxBenefitFromStockOptionsExercised1	840000	USD
CY2012Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-568000	USD
CY2013Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-2776000	USD
CY2012Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	898000	shares
CY2013Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51231000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51864000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50966000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51231000	shares
CY2013Q2	hae	Interest Rate Swap Asset Fair Value Disclosure InterestRateSwapAssetFairValueDisclosure	2312000	USD
CY2013Q2	hae	Other Comprehensive Income Lossbefore Reclassifications Netof Tax OtherComprehensiveIncomeLossbeforeReclassificationsNetofTax	1133000	USD
CY2013Q2	hae	Reclassificationfrom Accumulated Other Comprehensive Income Current Period Netof Tax ReclassificationfromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetofTax	1392000	USD
CY2013Q2	hae	Restructuring Charges Payablefrom Fiscal2015and Beyond RestructuringChargesPayablefromFiscal2015andBeyond	14700000	USD
CY2012Q2	hae	Reversal Of Interest Expense On Contingent Consideration ReversalOfInterestExpenseOnContingentConsideration	0	USD
CY2013Q2	hae	Reversal Of Interest Expense On Contingent Consideration ReversalOfInterestExpenseOnContingentConsideration	-121000	USD
CY2013Q2	hae	Stock Issued During Period Employee Stock Purchase Plans Price Per Share StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare	32.73
CY2012Q2	hae	Stock Issued During Period Employee Stock Purchase Plans Price Per Share StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare	24.92
CY2013Q2	hae	Term Of Each Fiscal Quarter TermOfEachFiscalQuarter	P364D
CY2013	hae	Term Of Each Fiscal Quarter TermOfEachFiscalQuarter	P364D
CY2013	hae	Term Of Each Quarter TermOfEachQuarter	P91D
CY2013Q2	hae	Term Of Each Quarter TermOfEachQuarter	P91D
CY2013Q2	hae	Total Other Assets TotalOtherAssets	633282000	USD
CY2013Q1	hae	Total Other Assets TotalOtherAssets	607954000	USD
CY2012Q2	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	7236000	USD
CY2013Q2	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	3357000	USD
CY2013Q2	dei	Amendment Flag AmendmentFlag	false
CY2013Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-30
CY2013Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2013Q2	dei	Document Period End Date DocumentPeriodEndDate	2013-06-29
CY2013Q2	dei	Document Type DocumentType	10-Q
CY2013Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000313143
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	51396952	shares
CY2013Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q2	dei	Entity Registrant Name EntityRegistrantName	HAEMONETICS CORP

Files In Submission

Name	View Source	Status
0000313143-13-000155-index-headers.html	Edgar Link	pending
0000313143-13-000155-index.html	Edgar Link	pending
0000313143-13-000155.txt	Edgar Link	pending
0000313143-13-000155-xbrl.zip	Edgar Link	pending
exhibit10j-englishtranslat.htm	Edgar Link	pending
exhibit10n-englishtranslat.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
hae-20130629.xml	Edgar Link	completed
hae-20130629.xsd	Edgar Link	pending
hae-20130629_cal.xml	Edgar Link	unprocessable
hae-20130629_def.xml	Edgar Link	unprocessable
hae-20130629_lab.xml	Edgar Link	unprocessable
hae-20130629_pre.xml	Edgar Link	unprocessable
haeq1201410q.htm	Edgar Link	pending
q12014exhibit311.htm	Edgar Link	pending
q12014exhibit312.htm	Edgar Link	pending
q12014exhibit321.htm	Edgar Link	pending
q12014exhibit322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HAE
HAEMONETICS CORP Stock $hae

2013 Q2 Form 10-Q Financial Statement

#000031314313000155 Filed on August 02, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE HAEMONETICS CORP Stock $hae

2013 Q2 Form 10-Q Financial Statement

#000031314313000155 Filed on August 02, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE
HAEMONETICS CORP Stock $hae